Efficacy, Safety, and Treatment Satisfaction of Once-Weekly Tirzepatide in Obese Type 2 Diabetic Patients

NCT07728318 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

52

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight

Interventions

OTHER: Tirzepatide + Standard Therapy (Intervention Group)
OTHER: Standard Oral Antidiabetic Drugs (OADs)

Sponsor

Akhtar Saeed Medical and Dental College